HOME >> BIOLOGY >> NEWS
March of the giant penguins

Giant prehistoric penguins? In Peru? It sounds more like something out of Hollywood than science, but a researcher from North Carolina State University along with U.S., Peruvian and Argentine collaborators has shown that two heretofore undiscovered penguin species reached equatorial regions tens of millions of years earlier than expected and during a period when the earth was much warmer than it is now.

Paleontologist Dr. Julia Clarke, assistant professor of marine, earth and atmospheric sciences at NC State with appointments at the North Carolina Museum of Natural Sciences and the American Museum of Natural History, and colleagues studied two newly discovered extinct species of penguins. Peruvian paleontologists discovered the new penguins sites in 2005.

The research is published online the week of June in Proceedings of the National Academy of Sciences. It was funded by the National Science Foundation Office of International Science and Engineering and the National Geographic Society.

The first of the new species, Icadyptes salasi, stood 5 feet tall and lived about 36 million years ago. The second new species, Perudyptes devriesi, lived about 42 million years ago, was approximately the same size as a living King Penguin (2 to 3 feet tall) and represents a very early part of penguin evolutionary history. Both of these species lived on the southern coast of Peru.

These new penguin fossils are among the most complete yet recovered and call into question hypotheses about the timing and pattern of penguin evolution and expansion. Previous theories held that penguins probably evolved in high latitudes (Antarctica and New Zealand) and then moved into lower latitudes that are closer to the equator about 10 million years ago long after significant global cooling that occurred about 34 million years ago.

We tend to think of penguins as being cold-adapted species, Clarke says, even the small penguins in equatori
'"/>

Contact: Tracey Peake
tracey_peake@ncsu.edu
919-515-6142
North Carolina State University
25-Jun-2007


Page: 1 2 3

Related biology news :

1. March of Dimes awards $250K prize to stem cell research, reproductive biology pioneers
2. ACS News Service Weekly PressPac -- March 28, 2007
3. ACS News Service Weekly PressPac -- March 21, 2007
4. National Academies advisory: March 27 release of report on metagenomics
5. JCI table of contents -- March 22, 2007
6. Other highlights from the March 21 JNCI
7. Story tips from the Department of Energys Oak Ridge National Laboratory, March 2007
8. Research and program highlights of the 2007 Annual Clinical Genetics Meeting, March 21-25, 2007
9. ACS News Service Weekly PressPac -- March. 14, 2007
10. Pioneering researcher Dr. Kenneth Lyons Jones receives genetics award from March of Dimes
11. JCI table of contents: March 15, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: March the giant penguins

(Date:5/10/2015)... , May 11, 2015 Fingerprint ... sensors FPC1025 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... will be used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK for ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has announced ... Outlook 2020 " report to their offering. ... medicine is expected to have huge marketing potential. Presently, ... the growth of deregulated organs. Several therapeutic molecules are ... form new tissue or sometimes organ transplant is required. ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: